News

On February 22, the Latvian Medicines Verification Organisation (LZVO) held a free seminar for manufacturers of medicines or marketing authorization holders (MAH) on the current developments related to the medicines verification system in Latvia and a look back on what was done in 2022.

To inform marketing authorization holders (MAHs) about the current events, the Latvian Medicines Verification Organisation (LZVO) will hold a special seminar on February 22, 2023.

Today, on February 9, it has been 4 years since the authenticity of medicinal products has been verified in the medicines verification system operating in all of Europe, including Latvia, where it is provided by the Latvian Medicines Verification System (LZVS).

Last year, in Latvia's legal medicines supply chain, through pharmacies and healthcare institutions, the residents received only safe prescription medicines and omeprazole, which were verified in the medicines verification system – slightly more than 28 million checked packages reached the population.

Summarizing what was done in 2022 and outlining the plans for 2023, the European Medicines Verification Organisation (EMVO) in cooperation with the National Medicines Verification Organisations has published the EMVS Community Newsletter – 2022 Holiday Bulletin edition. In this bulletin, Inese Erdmane, Chairwoman of the Board at the Latvian Medicines Verification Organisation (LZVO), also talks about this year's achievements.

On November 30, 2022, a General Assembly meeting of stakeholders of the Latvian Medicines Verification Organisation (LZVO) was held, where the strategy and budget for 2023 were approved.